Myasthenia gravis

Indication for Pyridostigmine

Population group: Suitable for both men and women, only children (1 year - 12 years old)
Therapeutic intent: Curative procedure

For this indication, competent medicine agencies globally authorize below treatments:

360 mg in 6 divided doses daily

Route of admnistration


Defined daily dose

30 - 60 mg

Dosage regimen

From 5 To 10 mg 6 time(s) per day every day

Detailed description

Children under 6 years old should receive an initial dose of half a tablet (30mg) of Mestinon; children 6–12 years old should receive one tablet (60mg). Dosage should be increased gradually, in increments of 15–30mg daily, until maximum improvement is obtained. Total daily requirements are usually in the range to 30–360mg.

Active ingredient

Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine.

Read more about Pyridostigmine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner